Telomir Pharmaceuticals, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Telomir Pharmaceuticals, Inc. (TELO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.14 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Telomir Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 6.99M shares, a 12.32% decline year-over-year.
- Telomir Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 7.97M shares, a 267.53% increase year-over-year.
- Telomir Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 5.19M shares, a 87.24% increase year-over-year.
- Telomir Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 2.82M shares, a 1.80% increase year-over-year.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2026-06-30 | 7.14M shares 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 6.99M shares 10-Q · filed 2026-05-14 | ||
| 2025-06-30 | 7.05M shares 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | 7.97M shares 10-Q · filed 2026-05-14 | ||
| 2024-09-30 | 5.19M shares 10-Q · filed 2024-11-12 | 5.19M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 2.82M shares 10-Q · filed 2024-08-13 | 2.82M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 2.17M shares 10-Q · filed 2024-05-13 | ||
| 2023-09-30 | 2.77M shares 10-Q · filed 2024-11-12 | 2.77M shares 10-Q · filed 2024-11-12 | |
| 2023-06-30 | 2.77M shares 10-Q · filed 2024-08-13 | 2.77M shares 10-Q · filed 2024-08-13 | |
| 2023-03-31 | 39.09K shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |